most of the B 12 secreted in the bile is recycled via enterohepatic circulation
Not for human consumption, medical use, or diagnostic purposes
The key findings from this clinical program include significant reductions in body weight and fat mass in treatment groups compared to placebo, preferential loss of abdominal and visceral adipose tissue, no changes in serum IGF-1 levels at any dose tested, no negative effects on glucose metabolism or insulin sensitivity, no significant adverse events related to metabolic or endocrine disruption, and safety profile indistinguishable from placebo for most parameters
However, a noticeable effect on weight loss and fat burning will probably take several days to several weeks, depending on the metabolism, age, health, and lifestyle
Important: 5-Amino-1MQ is a research compound and is not FDA-approved to treat any condition